CRO Update: Where are Contract Research Organizations Headed?
Applied Clinical Trials
; 31(3):18-23, 2022.
Artículo
en Inglés
| ProQuest Central | ID: covidwho-20243333
ABSTRACT
Goliath dynamic The CRO space has seen a flurry of merger and acquisition activity in recent years. 2016 saw the merger of IMS Health with Quintiles, resulting in the birth of IQVIA. "In a commoditized service area, scale is important, because it gives you a depth of business development and sales coverage in the market," Getz explains. John Kreger, an equity research analyst with William Blair in Chicago, IL, says the pharma industry's source of innovation has aggressively shifted from large pharmaceutical companies to small biotech startups. Coldwell says most CROs will forge partnership agreements with DCT software developers, but three or four of the world's largest CROs are building DCT technology in-house.
Buscar en Google
Colección:
Bases de datos de organismos internacionales
Base de datos:
ProQuest Central
Idioma:
Inglés
Revista:
Applied Clinical Trials
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS